Northland Capmk Equities Analysts Cut Earnings Estimates for DocGo Inc. (NASDAQ:DCGO)

DocGo Inc. (NASDAQ:DCGO - Free Report) - Stock analysts at Northland Capmk dropped their Q2 2024 earnings estimates for shares of DocGo in a research note issued on Tuesday, April 9th. Northland Capmk analyst M. Latimore now expects that the company will post earnings of $0.06 per share for the quarter, down from their prior forecast of $0.07. The consensus estimate for DocGo's current full-year earnings is $0.35 per share.

DocGo (NASDAQ:DCGO - Get Free Report) last issued its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.07). The firm had revenue of $199.25 million for the quarter, compared to analysts' expectations of $195.48 million. DocGo had a net margin of 1.10% and a return on equity of 2.01%.

DCGO has been the subject of several other research reports. Cantor Fitzgerald dropped their price objective on DocGo from $13.00 to $11.00 and set an "overweight" rating for the company in a research note on Thursday, February 29th. Canaccord Genuity Group decreased their price objective on shares of DocGo from $10.00 to $9.00 and set a "buy" rating on the stock in a research report on Thursday. BTIG Research dropped their target price on shares of DocGo from $13.00 to $11.00 and set a "buy" rating for the company in a research report on Wednesday. Needham & Company LLC cut their price target on shares of DocGo from $14.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, February 29th. Finally, Stifel Nicolaus dropped their price objective on shares of DocGo from $11.00 to $8.00 and set a "buy" rating for the company in a report on Wednesday. Five analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $10.83.

DocGo Trading Down 2.8 %

Shares of DCGO traded down $0.10 during mid-day trading on Friday, reaching $3.26. 1,058,568 shares of the stock traded hands, compared to its average volume of 1,600,399. The company has a market cap of $339.59 million, a price-to-earnings ratio of 46.57, a price-to-earnings-growth ratio of 0.34 and a beta of 0.91. DocGo has a 1 year low of $2.78 and a 1 year high of $10.82. The firm has a fifty day moving average price of $3.73 and a 200 day moving average price of $4.70.

Institutional Investors Weigh In On DocGo

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of DocGo by 2.8% in the fourth quarter. Vanguard Group Inc. now owns 4,804,845 shares of the company's stock worth $26,859,000 after buying an additional 132,263 shares during the period. Wolverine Trading LLC increased its position in shares of DocGo by 502.7% in the fourth quarter. Wolverine Trading LLC now owns 10,369 shares of the company's stock valued at $58,000 after acquiring an additional 12,944 shares during the period. Nuveen Asset Management LLC raised its stake in shares of DocGo by 23.8% during the fourth quarter. Nuveen Asset Management LLC now owns 505,877 shares of the company's stock valued at $2,828,000 after acquiring an additional 97,189 shares during the last quarter. Birchview Capital LP boosted its holdings in shares of DocGo by 15.4% during the fourth quarter. Birchview Capital LP now owns 150,000 shares of the company's stock worth $838,000 after purchasing an additional 20,000 shares during the period. Finally, Royal Bank of Canada grew its stake in shares of DocGo by 34.6% in the fourth quarter. Royal Bank of Canada now owns 45,157 shares of the company's stock worth $253,000 after purchasing an additional 11,602 shares during the last quarter. Institutional investors own 56.44% of the company's stock.

Insider Buying and Selling at DocGo

In other DocGo news, Director Michael J. Burdiek acquired 10,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was purchased at an average cost of $3.61 per share, for a total transaction of $36,100.00. Following the acquisition, the director now owns 571,595 shares in the company, valued at approximately $2,063,457.95. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 13.78% of the company's stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.